Search Results 1231-1240 of 38331 for Two-phase

  1. Ph. 1, Evaluation of Safety, Tolerability, PK, Anti-tumor Activity of STP707 IV in Subjects With Solid Tumors - Mayo Clinic

    Study phase. 1. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

  2. A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease - Mayo Clinic

    Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines ...

  3. Glioblastoma Clinical Trials - Mayo Clinic Research

    This is a multicenter, two-arm, randomized, double-blind, placebo ... Phase 2 ... Wild-Type Reovirus in Combination With Sargramostim in Treating ...

  4. Study to Evaluate the Safety and Effectiveness of Axicabtagene Ciloleucel in Combination With Utomilumab in Adults With Relapsed/Refractory Large B-cell Lymphoma - Mayo Clinic

    Study phase. 1. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

  5. Amyloidosis - Symptoms and causes - Mayo Clinic

    This rare disease caused by a buildup of the protein amyloid can affect different organs in different people. Find out how early and accurate diagnosis can ...

  6. Deucravacitinib (BMS-986165) for Pityriasis Rubra Pilaris - Mayo Clinic

    Study phase. 2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

  7. Efficacy and Safety of Tolvaptan in Subjects With Chronic Kidney Disease Between Late Stage 2 to Early Stage 4 Due to Autosomal Dominant Polycystic Kidney Disease - Mayo Clinic

    Efficacy and Safety of Tolvaptan in Subjects With Chronic Kidney Disease Between Late Stage 2 to Early Stage 4 Due to Autosomal Dominant Polycystic Kidney ...

  8. Targeted Drug Therapy Clinical Trials - Mayo Clinic Research

    This randomized phase II trial compares how well two different doses of carfilzomib work when given with dexamethasone in treating patients with multiple ...

  9. Hematology - Clinical trials

    ABBV-383 is an investigational drug being developed for the treatment of R/R Multiple Myeloma (MM). This study includes 2 parts; step-up dose optimization (Part ...

  10. Type 1 diabetes - Symptoms and causes - Mayo Clinic

    Type 1 diabetes can appear at any age, but it appears at two noticeable peaks. ... stage kidney disease that can't be reversed. End-stage kidney disease ...